Cargando…
Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
Echinocandin antifungal agents have become the first-line therapy for invasive candidiasis (IC) in many countries. Despite their increasing use, resistance to this class of drug is, overall, still uncommon. Here, we report two patients from the People’s Republic of China with IC, one with infection...
Autores principales: | Xiao, Meng, Fan, Xin, Hou, Xin, Chen, Sharon CA, Wang, He, Kong, Fanrong, Sun, Zi-Yong, Chu, Yun-Zhuo, Xu, Ying-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790075/ https://www.ncbi.nlm.nih.gov/pubmed/29416360 http://dx.doi.org/10.2147/IDR.S152785 |
Ejemplares similares
-
P017 Echinocandin resistance mechanism in Candida tropicalis and Candida glabrata
por: Sharma, Dipti, et al.
Publicado: (2022) -
Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016) -
Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017) -
Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
por: Hernando-Ortiz, Ainara, et al.
Publicado: (2021) -
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018)